about
Extracellular Vesicles As Modulators of Tumor Microenvironment and Disease Progression in GliomaGene Expression Profiling of Chemokines and Their Receptors in Low and High Grade AstrocytomaChemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis toolBiodegradable brain-penetrating DNA nanocomplexes and their use to treat malignant brain tumors.The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models.Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis.Cancer stem cells: The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells.The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomasMultiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression.Lysophosphatidic acid via LPA-receptor 5/protein kinase D-dependent pathways induces a motile and pro-inflammatory microglial phenotype.ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance.5-Aminolevulinic Acid Guided Sampling of Glioblastoma Microenvironments Identifies Pro-Survival Signaling at Infiltrative Margins.Molecular Determinants of Malignant Brain Cancers: From Intracellular Alterations to Invasion Mediated by Extracellular Vesicles.Periarteriolar Glioblastoma Stem Cell Niches Express Bone Marrow Hematopoietic Stem Cell Niche Proteins.Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas.Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma.Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).Intratumoral heterogeneity of oxygen metabolism and neovascularization uncovers 2 survival-relevant subgroups of IDH1 wild-type glioblastomaInteraction of hematopoietic CD34+ CD45+ stem cells and cancer cells stimulated by TGF‑β1 in a model of glioblastoma in vitroSignificance of Glioma Stem-Like Cells in the Tumor Periphery That Express High Levels of CD44 in Tumor Invasion, Early Progression, and Poor Prognosis in GlioblastomaAn overview of MCT1 and MCT4 in GBM: small molecule transporters with large implicationsIL-8/CXCR1/2 signalling promotes tumor cell proliferation, invasion and vascular mimicry in glioblastoma
P2860
Q33876259-1DF85C80-3C78-4F9E-881D-53DB15BE2D9AQ38432528-353EC7C2-D21D-4C05-AFBD-E6FC6D9E4F8CQ38611037-31F20FF7-41A7-480F-BED9-7623EBFB30B4Q38685603-C3C0D8E2-7EF5-460B-B323-CE1180B63969Q38699394-5DBEBBAC-5881-448B-AD4C-0915AF6BCDADQ39196377-1A298D0A-5783-4440-9B80-467E8132402EQ39202839-0476DD15-3C5D-49F8-AAD5-3AE165ACB1CEQ41612669-E47AE810-174E-4C02-A575-E51B1D5CF703Q45869675-1E800917-1138-45E9-9F6E-77110AB42D51Q47118425-BEBD621C-1708-4D0F-9B51-847D4AE14D22Q47118535-F5C8DF71-909E-4B69-BE11-45F3EBA440F3Q47134867-CF84576C-03A1-4452-9A1A-E5A76CA1C73FQ47183915-6614F3D3-858C-4866-809D-6A570F592473Q47235352-C46399E9-B800-44C3-937D-7767BADB83D5Q47912595-FD080FA3-BEF2-43B3-BA80-A51C8B0E510DQ48293592-B495EDC0-0F63-42E7-A107-35A0EA228DADQ52629217-8548A7DF-31A6-4EA0-8D0B-F7638B555474Q55509415-8C3C9E1E-92C8-4616-9128-79C91D0DF19AQ57291654-13AA99A6-328F-4843-92A3-4652E05D40DAQ58704491-21E31712-6CBE-4D07-9326-3B07E88D70C5Q58711755-2E70879D-5EBE-41A4-84B4-0A6909475D6AQ58790007-0570A830-00FB-4C9A-B372-B4DE1A8871C0Q58796360-FBCEA7EF-9105-456F-96D5-F9303D906D45
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Glioblastoma: Defining Tumor Niches.
@en
type
label
Glioblastoma: Defining Tumor Niches.
@en
prefLabel
Glioblastoma: Defining Tumor Niches.
@en
P2860
P1433
P1476
Glioblastoma: Defining Tumor Niches.
@en
P2093
Dolores Hambardzumyan
Gabriele Bergers
P2860
P304
P356
10.1016/J.TRECAN.2015.10.009
P577
2015-12-01T00:00:00Z